Company page

Organogenesis Holdings Inc.

Organogenesis Holdings Inc. (ticker: ORGO) is a publicly traded company based in the United States, with a market capitalization of approximately $314 million. The company specializes in regenerative medicine and provides advanced wound care and surgical biologics products. Organogenesis focuses on developing innovative solutions to improve patient outcomes in various medical fields.